Skip to main content
. Author manuscript; available in PMC: 2016 Dec 23.
Published in final edited form as: N Engl J Med. 2016 Jun 23;374(25):2419–2429. doi: 10.1056/NEJMoa1510093

Figure 2. Progression-free and Overall Survival.

Figure 2

Panel A shows progression-free survival among patients with negative PET findings after two cycles of ABVD who underwent randomization, Panel B overall survival among patients with negative PET findings who underwent randomization, Panel C progression-free survival among patients with positive PET findings, and Panel D overall survival among patients with positive PET findings.